International workgroup issues additional guidance on how to manage patients who carry inherited CHEK2 gene mutations that put them at a higher risk for cancer.

Levels of the essential, branched-chain amino acids, valine, leucine and isoleucine, are involved in the regulation of lipid, glucose and protein metabolism.

The Vanderbilt Transplant Center (VTC) established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.

Margaret Salisbury, MD, MS, a leader in the study and treatment of interstitial lung diseases at Vanderbilt University Medical Center, has received a Young Physician-Scientist Award from the Council of the American Society for Clinical Investigation (ASCI) for “notable achievements” in research.

Vanderbilt's Stokes Peebles, MD, has been appointed to the National Advisory Allergy and Infectious Diseases Council.

Vanderbilt University Medical Center has been awarded a $5 million grant from the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute to establish a multidisciplinary center focused on training scientists and supporting research to minimize gaps between the generation of clinical evidence, implementation of proven interventions and development of informed public health policy.

The current standard of care for identifying targetable mutations in cancer treatment is to conduct molecular profiles on tumor tissue samples, but a study published Monday in JAMA Network Open indicates that adding liquid biopsy testing for circulating tumor DNA mutations increases targetable mutation detection rates.

Katherine Hartmann, MD, PhD, Vice President for Research Integration for Vanderbilt University Medical Center, has been named director of the University of Kentucky (UK) Center for Clinical and Translational Science. She will also serve as associate vice president for Research, Clinical & Translational Science for UK, and she will be the associate dean of Research Development and Synergy and a professor of Obstetrics and Gynecology in the UK College of Medicine. She will join UK on Feb. 15.

The STAR Clinical Research Network, based at Vanderbilt University Medical Center (VUMC), has added two new partners — Essentia Health, a Minnesota-based rural health care system, and Stanford University School of Medicine, one of the country’s leading academic medical centers.

A new study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity.